Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 36, Issue 6, 2009, Pages 1052-1057

  Phernambucq, Erik C J ^a   Spoelstra, Femke O B ^a   Paul, Marinus A ^a   Senan, Suresh ^a   Melissant, Christian F ^b   Postmus, Pieter E ^a   Smit, Egbert F ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Orthopaedic Surgery   (Netherlands)

Author keywords

Chemoradiotherapy; Induction therapy; NSCLC; Stage III; Surgery; Trimodality

Indexed keywords

APREPITANT; CISPLATIN; DEXAMETHASONE; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; ONDANSETRON;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; ENDOSCOPY; ESOPHAGITIS; FEBRILE NEUTROPENIA; FEMALE; HISTOPATHOLOGY; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; MEDIASTINOSCOPY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION PNEUMONIA; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TREATMENT PLANNING; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PROSPECTIVE STUDIES; RADIOTHERAPY, HIGH-ENERGY; TREATMENT OUTCOME;

EID: 70449530732     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.05.025     Document Type: Article

References (23)

1. Johnson D.H., Rusch V.W., and Turrisi A.T. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 99 (2007) 415-418
2. Robinson L.A., Ruckdeschel J.C., Wagner Jr. H., and Stevens C.W. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 (2007) 243S-265S
3. Jett J.R., Schild S.E., Keith R.L., and Kesler K.A. Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 (2007) 266S-276S
4. Shen K.R., Meyers B.F., Larner J.M., and Jones D.R. Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 (2007) 290S-305S
5. van Meerbeeck J.P., Kramer G.W., Van Schil P.E., Legrand C., Smit E.F., Schramel F., Tjan-Heijnen V.C., Biesma B., Debruyne C., van Zandwijk N., Splinter T.A.W., and Giaccone G. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 99 (2007) 442-450
6. Albain K.S., Schwann R.S., Rusch V.R., Turrisi A.T., Shepherd F.A., Smith C.J., Gandara D.R., Johnson D.H., Green M.R., and Miller R.C. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs. CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer: outcomes update of North American Intergroup: Intergroup trial 0139. Proc Am Soc Clin Oncol 23 (2005) 624S [abstr 7014]
7. Machtay M., Hsu C., Komaki R., Sause W.T., Swann R.S., Langer C.J., Byhardt R.W., and Curran W.J. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int J Radiat Oncol Biol Phys 63 (2005) 667-671
8. Turrisi A.T., Scott C.B., Rusch V.R., Albain K.S., Shepherd F.S., Smith C., Chen Y., Livingston R., Gandara D.R., Darling G., Johnson D.H., and Green M.R. Randomized trial of chemoradiotherapy to 61 Gy [no S] versus chemoradiotherapy to 45 Gy followed by surgery [S] using cisplatin etoposide in stage IIIa non-small cell lung cancer (NSCLC): intergroup trial 0139, RTOG (9309). Int J Radiat Oncol Biol Phys 57 (2003) S125-S126
9. Yuan S., Sun X., Li M., Yu J., Ren R., Yu Y., Li J., Liu X., Wang R., Li B., Kong L., and Yin Y. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 30 (2007) 239-244
10. Haasbeek C.J., Slotman B.J., and Senan S. Radiotherapy for lung cancer: clinical impact of recent technical advances. Lung Cancer 64 (2009) 1-8
11. Spoelstra F.O., van Sörnsen de Koste J.R., Cuijpers J.P., Lagerwaard F.J., Slotman B.J., and Senan S. Analysis of reproducibility of respiration-triggered gated radiotherapy for lung tumors. Radiother Oncol 87 (2008) 59-64
12. Senan S., De Ruyscher D., Giraud P., Mirimanoff R., and Budach V. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer; Radiotherapy Group of European Organization for Research and Treatment of Cancer. Radiother Oncol 71 (2004) 139-146
13. Bethesda MD. International Commission on Radiation Units and Measurements. ICRU report 62: prescribing, recording, and reporting photon beam therapy; 1999 [Supplement to ICRU report 50].
14. Underberg R.W., van Sörnsen de Koste J.R., Lagerwaard F.J., Vincent A., Slotman B.J., and Senan S. A dosimetric analysis of respiration-gated radiotherapy in stage III lung cancer. Radiat Oncol 31 (2006) 1-8
15. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., Verweij J., van Glabbeke M., van Oosterom A.T., Christian M.C., and Gwyther S.G. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
16. Kunst P.W., Lee P., Paul M.A., Senan S., and Smit E.F. Restaging of mediastinal nodes with transbronchial needle aspiration after induction chemoradiation for locally advanced non-small cell lung cancer. J Thorac Oncol 2 (2007) 912-915
17. Kaplan E., and Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
18. Rusch V.W., Giroux D.J., Kraut M.J., Crowley J., Hazuka M., Winton T., Johnson D.H., Shulman L., Shepherd F., Deschamps C., Livingston R.B., and Gandara D. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 25 (2007) 313-318
19. Cerfolio R.J., Maniscalco L., and Bryant A.S. The treatment of patients with stage IIIA non-small cell lung cancer from N2 disease: who returns to the surgical arena and who survives. Ann Thorac Surg 86 (2008) 912-920
20. Clamon G., Herndon J., Cooper R., Chang A.Y., Rosenman J., and Green M.R. Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 17 (1999) 4-11
21. Groen H.J., van der Leest A.H., Fokkema E., Timmer P.R., Nossent G.D., Smit W.J., Nabers J., Hoekstra H.J., Hermans J., Otter R., van Putten J.W., de Vries E.G., and Mulder N.H. Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Ann Oncol 15 (2004) 427-432
22. Chen A.M., Jahan T.M., Jablons D.M., Garcia J., and Larson D.A. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced non-small-cell lung cancer: clinical implications for the subsequent management of the brain. Cancer 109 (2007) 1668-1675
23. Pöttgen C., Eberhardt W., Grannass A., Korfee S., Stüben G., Teschler H., Stamatis G., Wagner H., Passlick B., Petersen V., Budach V., Wilhelm H., Wanke I., Hirche H., Wilke H.J., and Stuschke M. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial. J Clin Oncol 25 (2007) 4987-4992